Cargando…
Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin via Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway
Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling...
Autores principales: | Wang, Hui, Sun, Wei, Zhang, Wen-Zhong, Ge, Chun-Yan, Zhang, Jing-Tao, Liu, Zhong-Yan, Fan, Yue-Zu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014585/ https://www.ncbi.nlm.nih.gov/pubmed/24811250 http://dx.doi.org/10.1371/journal.pone.0096982 |
Ejemplares similares
-
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway
por: Zhang, Jing-Tao, et al.
Publicado: (2014) -
Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression
por: Wang, Zhenyu, et al.
Publicado: (2017) -
Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023) -
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro
por: Sun, Wei, et al.
Publicado: (2011) -
LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)